#treatment - Techseriesinsight

May 29, 2025
PRNewswire
Data Management Platform

Brainomix Driving Treatment Decisions in Stroke: New Studies Presented at Leading European Stroke Conference

Brainomix, a global leader in AI-powered imaging solutions in stroke and lung fibrosis, presented a series of new studies at the European Stroke Organisation Conference (ESOC) in Helsinki, solidifying the position...

May 26, 2025
PRNewswire
Biotechnology

Dizal to Highlight its Portfolio Advances in Hematologic Malignancies and Lung Cancer at ASCO 2025

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today that it will present latest clinical study results of...

May 23, 2025
PRNewswire
Healthcare

Oncolytics Biotech® to Present New Clinical Trial Data at ASCO Showing Pelareorep’s Unique Immune Activation Capabilities

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced new data from the Phase I/II GOBLET clinical trial in a poster presentation...

May 19, 2025
PRNewswire
Biotechnology

Cytora Reports Phase 1 Data of Stem Cell Treatment for Multiple System Atrophy

Cytora, a clinical stage company developing unique stem cell treatments based on human Oral Mucosa Stem Cells (hOMSC), reported today data of an ongoing Phase 1 clinical study for treating...

May 15, 2025
PRNewswire
Artificial Intelligence

MILLENNIUM DENTAL TECHNOLOGIES LAUNCHES LANAP® AI WORKFLOW

Millennium Dental Technologies, Inc., the leader in laser-assisted regeneration (LAR) technology and innovative procedures, announced at the annual California Dental Association (CDA) convention in Anaheim the launch of the LANAP® AI Workflow...

May 15, 2025
PRNewswire
Biotechnology

Dizal to Present Promising Clinical Data on Golidocitinib and DZD8586 for the Treatment of Lymphoma at the Coming International Hematology Conferences

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced that the latest data from eight hematologic malignancy clinical trials...

May 14, 2025
PRNewswire
Biotechnology

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from Plasma

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced the publication (https://www.biorxiv.org/cgi/content/short/2025.05.09.652772v1) of a pre-clinical ex vivo study...

May 13, 2025
PRNewswire
Healthcare

Duchesnay USA and MyMenopauseRx join in a partnership to offer expert consultations for menopausal women

Duchesnay USA, a specialty pharmaceutical company dedicated to women’s health and part of Duchesnay Pharmaceutical Group (DPG), is pleased to announce a strategic partnership with MyMenopauseRx, a virtual doctor’s office...

May 9, 2025
PRNewswire
Healthcare

Osteotec Signs Exclusive Distribution Agreement with icotec ag to advance Spine Tumour Therapy in Great Britain

Osteotec, the market leading manufacturer and distributor of specialised medical devices, is pleased to announce an exclusive distribution agreement with icotec, the world leader of non-metallic spinal implants optimized...

May 8, 2025
PRNewswire
Biotechnology

Ratio Therapeutics to Establish New Radiopharmaceutical Manufacturing Facility

Ratio Therapeutics Inc. (Ratio), a pharmaceutical company employing innovative technologies to develop best-in-class radiopharmaceuticals for cancer treatment and monitoring, today announced that it entered into an agreement with the...